Xilong Scientific Past Earnings Performance
Past criteria checks 4/6
Xilong Scientific has been growing earnings at an average annual rate of 3.2%, while the Chemicals industry saw earnings growing at 7.8% annually. Revenues have been growing at an average rate of 15% per year. Xilong Scientific's return on equity is 1.4%, and it has net margins of 0.4%.
Key information
3.2%
Earnings growth rate
3.7%
EPS growth rate
Chemicals Industry Growth | 12.1% |
Revenue growth rate | 15.0% |
Return on equity | 1.4% |
Net Margin | 0.4% |
Next Earnings Update | 24 Aug 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Xilong Scientific makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 7,936 | 30 | 249 | 110 |
31 Dec 23 | 7,693 | 33 | 243 | 96 |
30 Sep 23 | 7,699 | 16 | 212 | 84 |
30 Jun 23 | 7,198 | 17 | 216 | 70 |
31 Mar 23 | 6,750 | 20 | 213 | 87 |
01 Jan 23 | 6,183 | 89 | 224 | 90 |
30 Sep 22 | 4,778 | 119 | 242 | 109 |
30 Jun 22 | 4,785 | 126 | 242 | 133 |
31 Mar 22 | 5,169 | 252 | 237 | 117 |
01 Jan 22 | 5,380 | 187 | 261 | 119 |
30 Sep 21 | 6,599 | 170 | 191 | 127 |
30 Jun 21 | 6,197 | 163 | 217 | 116 |
31 Mar 21 | 6,515 | 78 | 284 | 105 |
31 Dec 20 | 6,243 | 57 | 265 | 103 |
30 Sep 20 | 5,509 | 59 | 339 | 87 |
30 Jun 20 | 4,993 | 49 | 347 | 82 |
31 Mar 20 | 3,713 | 51 | 303 | 85 |
31 Dec 19 | 3,338 | 39 | 303 | 88 |
30 Sep 19 | 3,093 | 17 | 342 | 88 |
30 Jun 19 | 3,252 | 39 | 318 | 89 |
31 Mar 19 | 3,610 | 44 | 333 | 83 |
31 Dec 18 | 3,355 | 71 | 339 | 82 |
30 Sep 18 | 3,511 | 103 | 308 | 74 |
30 Jun 18 | 3,444 | 101 | 279 | 94 |
31 Mar 18 | 3,351 | 93 | 282 | 77 |
31 Dec 17 | 3,305 | 90 | 282 | 59 |
30 Sep 17 | 3,572 | 77 | 303 | 38 |
30 Jun 17 | 3,422 | 77 | 339 | 0 |
31 Mar 17 | 3,166 | 87 | 327 | 0 |
31 Dec 16 | 2,928 | 97 | 316 | 0 |
30 Sep 16 | 2,641 | 100 | 294 | 0 |
30 Jun 16 | 2,531 | 98 | 288 | 0 |
31 Mar 16 | 2,495 | 94 | 279 | 0 |
31 Dec 15 | 2,514 | 91 | 275 | 0 |
30 Sep 15 | 2,224 | 92 | 273 | 0 |
30 Jun 15 | 2,214 | 84 | 272 | 0 |
31 Mar 15 | 2,202 | 76 | 258 | 0 |
31 Dec 14 | 2,198 | 78 | 254 | 0 |
30 Sep 14 | 2,236 | 69 | 230 | 0 |
30 Jun 14 | 2,261 | 61 | 216 | 0 |
31 Mar 14 | 2,321 | 53 | 211 | 0 |
31 Dec 13 | 2,240 | 49 | 194 | 0 |
30 Sep 13 | 2,011 | 50 | 193 | 0 |
Quality Earnings: 002584 has a large one-off gain of CN¥18.1M impacting its last 12 months of financial results to 31st March, 2024.
Growing Profit Margin: 002584's current net profit margins (0.4%) are higher than last year (0.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 002584's earnings have grown by 3.2% per year over the past 5 years.
Accelerating Growth: 002584's earnings growth over the past year (49.5%) exceeds its 5-year average (3.2% per year).
Earnings vs Industry: 002584 earnings growth over the past year (49.5%) exceeded the Chemicals industry -16.4%.
Return on Equity
High ROE: 002584's Return on Equity (1.4%) is considered low.